Yaky Yanay
2010
In 2010, Yaky Yanay earned a total compensation of $289K as Chief Financial Officer at Pluristem Therapeutics, a 9% decrease compared to previous year.
Compensation breakdown
| Salary | $159,820 |
|---|---|
| Stock Awards | $107,362 |
| Other | $21,821 |
| Total | $289,003 |
Yanay received $159.8K in salary, accounting for 55% of the total pay in 2010.
Yanay also received $107.4K in stock awards and $21.8K in other compensation.
Rankings
In 2010, Yaky Yanay's compensation ranked 9,150th out of 10,439 executives tracked by ExecPay. In other words, Yanay earned more than 12.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,150 out of 10,439 | 12th |
Division Manufacturing | 3,409 out of 3,838 | 11th |
Major group Chemicals And Allied Products | 821 out of 921 | 11th |
Industry group Drugs | 597 out of 680 | 12th |
Industry Biological Products, Except Diagnostic Substances | 122 out of 142 | 14th |
Source: SEC filing on April 15, 2011.
Yanay's colleagues
We found one more compensation record of an executive who worked with Yaky Yanay at Pluristem Therapeutics in 2010.
2010
Zami Aberman
Pluristem Therapeutics
Chief Executive Officer
News
Pluristem Therapeutics CEO Yaky Yanay's 2023 pay jumps 111% to $2.7M
May 1, 2024
Pluristem Therapeutics CEO Yaky Yanay's 2022 pay falls 86% to $1.3M
February 27, 2023
Pluristem Therapeutics Chairman Zami Aberman's 2020 pay falls 54% to $501K
April 8, 2021
Pluristem Therapeutics Chairman Zami Aberman's 2019 pay jumps 85% to $1.1M
May 20, 2020
Pluristem Therapeutics CEO Zami Aberman's 2018 pay falls 83% to $593K
April 25, 2019